Fewer Biotech-Pharma M&As But Tie-ups Indicate New China Trends

 
• By Dexter Jie Yan
  
Two arrows joining
Chinese biotechs and major pharma converged in a shared innovation drive in 2022 • Source: Shutterstock

More from China

More from Focus On Asia